1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Immunoinformatics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cancer Diagnosis & Therapy
  • 1.2.3 Reverse Vaccinology
  • 1.2.4 Immune System Modeling
• 1.3 Market by Application
  • 1.3.1 Global Immunoinformatics Market Share by Application: 2020 VS 2026
  • 1.3.2 Allergy Prediction Databases
  • 1.3.3 Analysis Resource Database
  • 1.3.4 International Immunogenetics System
  • 1.3.5 The Ontology Of Immune Epitopes
  • 1.3.6 Immune Epitope Database
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Immunoinformatics Market Perspective (2015-2026)
• 2.2 Global Immunoinformatics Growth Trends by Regions
  • 2.2.1 Immunoinformatics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Immunoinformatics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Immunoinformatics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Immunoinformatics Players by Market Size
  • 3.1.1 Global Top Immunoinformatics Players by Revenue (2015-2020)
  • 3.1.2 Global Immunoinformatics Revenue Market Share by Players (2015-2020)
• 3.2 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Immunoinformatics Revenue
• 3.4 Global Immunoinformatics Market Concentration Ratio
  • 3.4.1 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Immunoinformatics Revenue in 2019
• 3.5 Key Players Immunoinformatics Area Served
• 3.6 Key Players Immunoinformatics Product Solution and Service
• 3.7 Date of Enter into Immunoinformatics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Immunoinformatics Breakdown Data by Type (2015-2026)

• 4.1 Global Immunoinformatics Historic Market Size by Type (2015-2020)
• 4.2 Global Immunoinformatics Forecasted Market Size by Type (2021-2026)

5 Immunoinformatics Breakdown Data by Application (2015-2026)

• 5.1 Global Immunoinformatics Historic Market Size by Application (2015-2020)
• 5.2 Global Immunoinformatics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Immunoinformatics Market Size (2015-2026)
• 6.2 North America Immunoinformatics Market Size by Type (2015-2020)
• 6.3 North America Immunoinformatics Market Size by Application (2015-2020)
• 6.4 North America Immunoinformatics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Immunoinformatics Market Size (2015-2026)
• 7.2 Europe Immunoinformatics Market Size by Type (2015-2020)
• 7.3 Europe Immunoinformatics Market Size by Application (2015-2020)
• 7.4 Europe Immunoinformatics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Immunoinformatics Market Size (2015-2026)
• 8.2 China Immunoinformatics Market Size by Type (2015-2020)
• 8.3 China Immunoinformatics Market Size by Application (2015-2020)
• 8.4 China Immunoinformatics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Immunoinformatics Market Size (2015-2026)
• 9.2 Japan Immunoinformatics Market Size by Type (2015-2020)
• 9.3 Japan Immunoinformatics Market Size by Application (2015-2020)
• 9.4 Japan Immunoinformatics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Immunoinformatics Market Size (2015-2026)
• 10.2 Southeast Asia Immunoinformatics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Immunoinformatics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Immunoinformatics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 EpiVax
  • 11.1.1 EpiVax Company Details
  • 11.1.2 EpiVax Business Overview
  • 11.1.3 EpiVax Immunoinformatics Introduction
  • 11.1.4 EpiVax Revenue in Immunoinformatics Business (2015-2020))
  • 11.1.5 EpiVax Recent Development
• 11.2 Novozymes Biopharma
  • 11.2.1 Novozymes Biopharma Company Details
  • 11.2.2 Novozymes Biopharma Business Overview
  • 11.2.3 Novozymes Biopharma Immunoinformatics Introduction
  • 11.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2015-2020)
  • 11.2.5 Novozymes Biopharma Recent Development
• 11.3 ioGenetics
  • 11.3.1 ioGenetics Company Details
  • 11.3.2 ioGenetics Business Overview
  • 11.3.3 ioGenetics Immunoinformatics Introduction
  • 11.3.4 ioGenetics Revenue in Immunoinformatics Business (2015-2020)
  • 11.3.5 ioGenetics Recent Development
• 11.4 International Society of Vaccines
  • 11.4.1 International Society of Vaccines Company Details
  • 11.4.2 International Society of Vaccines Business Overview
  • 11.4.3 International Society of Vaccines Immunoinformatics Introduction
  • 11.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2015-2020)
  • 11.4.5 International Society of Vaccines Recent Development
• 11.5 IMGT
  • 11.5.1 IMGT Company Details
  • 11.5.2 IMGT Business Overview
  • 11.5.3 IMGT Immunoinformatics Introduction
  • 11.5.4 IMGT Revenue in Immunoinformatics Business (2015-2020)
  • 11.5.5 IMGT Recent Development
• 11.6 Dassault Systemes
  • 11.6.1 Dassault Systemes Company Details
  • 11.6.2 Dassault Systemes Business Overview
  • 11.6.3 Dassault Systemes Immunoinformatics Introduction
  • 11.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2015-2020)
  • 11.6.5 Dassault Systemes Recent Development
• 11.7 Certara
  • 11.7.1 Certara Company Details
  • 11.7.2 Certara Business Overview
  • 11.7.3 Certara Immunoinformatics Introduction
  • 11.7.4 Certara Revenue in Immunoinformatics Business (2015-2020)
  • 11.7.5 Certara Recent Development
• 11.8 Chemical Computing Group
  • 11.8.1 Chemical Computing Group Company Details
  • 11.8.2 Chemical Computing Group Business Overview
  • 11.8.3 Chemical Computing Group Immunoinformatics Introduction
  • 11.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2015-2020)
  • 11.8.5 Chemical Computing Group Recent Development
• 11.9 Compugen
  • 11.9.1 Compugen Company Details
  • 11.9.2 Compugen Business Overview
  • 11.9.3 Compugen Immunoinformatics Introduction
  • 11.9.4 Compugen Revenue in Immunoinformatics Business (2015-2020)
  • 11.9.5 Compugen Recent Development
• 11.10 Genedata AG
  • 11.10.1 Genedata AG Company Details
  • 11.10.2 Genedata AG Business Overview
  • 11.10.3 Genedata AG Immunoinformatics Introduction
  • 11.10.4 Genedata AG Revenue in Immunoinformatics Business (2015-2020)
  • 11.10.5 Genedata AG Recent Development
• 11.11 Insilico Biotechnology AG
  • 10.11.1 Insilico Biotechnology AG Company Details
  • 10.11.2 Insilico Biotechnology AG Business Overview
  • 10.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
  • 10.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2015-2020)
  • 10.11.5 Insilico Biotechnology AG Recent Development
• 11.12 Leadscope Inc
  • 10.12.1 Leadscope Inc Company Details
  • 10.12.2 Leadscope Inc Business Overview
  • 10.12.3 Leadscope Inc Immunoinformatics Introduction
  • 10.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2015-2020)
  • 10.12.5 Leadscope Inc Recent Development
• 11.13 Nimbus Discovery
  • 10.13.1 Nimbus Discovery Company Details
  • 10.13.2 Nimbus Discovery Business Overview
  • 10.13.3 Nimbus Discovery Immunoinformatics Introduction
  • 10.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2015-2020)
  • 10.13.5 Nimbus Discovery Recent Development
• 11.14 Strand Life Sciences
  • 10.14.1 Strand Life Sciences Company Details
  • 10.14.2 Strand Life Sciences Business Overview
  • 10.14.3 Strand Life Sciences Immunoinformatics Introduction
  • 10.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2015-2020)
  • 10.14.5 Strand Life Sciences Recent Development
• 11.15 Schrodinger
  • 10.15.1 Schrodinger Company Details
  • 10.15.2 Schrodinger Business Overview
  • 10.15.3 Schrodinger Immunoinformatics Introduction
  • 10.15.4 Schrodinger Revenue in Immunoinformatics Business (2015-2020)
  • 10.15.5 Schrodinger Recent Development
• 11.16 Simulation Plus
  • 10.16.1 Simulation Plus Company Details
  • 10.16.2 Simulation Plus Business Overview
  • 10.16.3 Simulation Plus Immunoinformatics Introduction
  • 10.16.4 Simulation Plus Revenue in Immunoinformatics Business (2015-2020)
  • 10.16.5 Simulation Plus Recent Development
• 11.17 Rosa & Co
  • 10.17.1 Rosa & Co Company Details
  • 10.17.2 Rosa & Co Business Overview
  • 10.17.3 Rosa & Co Immunoinformatics Introduction
  • 10.17.4 Rosa & Co Revenue in Immunoinformatics Business (2015-2020)
  • 10.17.5 Rosa & Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Immunoinformatics Scope and Market Size
Immunoinformatics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunoinformatics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Market segment by Application, split into
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database

Based on regional and country-level analysis, the Immunoinformatics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Immunoinformatics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co